ResMed (NYSE:RMD) reported its Q2 earnings results on Wednesday, January 24, 2024 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
ResMed beat estimated earnings by 5.03%, reporting an EPS of $1.88 versus an estimate of $1.79.
Revenue was up $129.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 2.94% drop in the share price the next day.
Here’s a look at ResMed’s past performance:
| Quarter | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| EPS Estimate | 1.62 | 1.67 | 1.59 | 1.60 |
| EPS Actual | 1.64 | 1.60 | 1.68 | 1.66 |
| Revenue Estimate | 1.10B | 1.12B | 1.05B | 994.02M |
| Revenue Actual | 1.10B | 1.12B | 1.12B | 1.03B |
To track all earnings releases for ResMed visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
